
### [NCIT:C4621](http://purl.obolibrary.org/obo/NCIT_C4621)
**Label:** Benign Endocrine Neoplasm

**Subclasses:** [NCIT:C48285](http://purl.obolibrary.org/obo/NCIT_C48285) (Parathyroid Gland Atypical Adenoma), [NCIT:C48283](http://purl.obolibrary.org/obo/NCIT_C48283) (Parathyroid Gland Lipoadenoma), [NCIT:C3502](http://purl.obolibrary.org/obo/NCIT_C3502) (Thyroid Gland Follicular Adenoma), [NCIT:C46111](http://purl.obolibrary.org/obo/NCIT_C46111) (Thyroid Gland Follicular Adenoma with Papillary Hyperplasia), [NCIT:C48458](http://purl.obolibrary.org/obo/NCIT_C48458) (Non-Functioning Adrenal Cortex Adenoma), [NCIT:C7993](http://purl.obolibrary.org/obo/NCIT_C7993) (Parathyroid Gland Clear Cell Adenoma), [NCIT:C4154](http://purl.obolibrary.org/obo/NCIT_C4154) (Parathyroid Gland Chief Cell Adenoma), [NCIT:C7994](http://purl.obolibrary.org/obo/NCIT_C7994) (Parathyroid Gland Mixed Cell Type Adenoma), [NCIT:C4167](http://purl.obolibrary.org/obo/NCIT_C4167) (Adrenal Cortex Mixed Cell Adenoma), [NCIT:C46118](http://purl.obolibrary.org/obo/NCIT_C46118) (Thyroid Gland Lipoadenoma), [NCIT:C9003](http://purl.obolibrary.org/obo/NCIT_C9003) (Adrenal Cortex Adenoma), [NCIT:C48449](http://purl.obolibrary.org/obo/NCIT_C48449) (Cortisol-Producing Adrenal Cortex Adenoma), [NCIT:C3916](http://purl.obolibrary.org/obo/NCIT_C3916) (Parathyroid Gland Adenoma), [NCIT:C27393](http://purl.obolibrary.org/obo/NCIT_C27393) (Parathyroid Gland Oncocytic Adenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 54.55%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 54.55%
- Thing 52.66%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 39.90%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39088](http://purl.obolibrary.org/obo/NCIT_C39088) (G2/M Checkpoint Pathway))) 39.90%


